Yu Zhong

GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer

Jun Liang, Robert A. Blake, Jae H. Chang et al. · Journal of Medicinal Chemistry · 2021 · 135 citations · Full text

Medicine, Oncology, Pharmacology +15

Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc

Yu Zhong, Liting Yang, Fang Xiong et al. · Signal Transduction and Targeted Therapy · 2021 · 110 citations · Full text

Medicine, Molecular Biology, Oncology +17

Diagnostic accuracy of sub-mSv prospective ECG-triggering cardiac CT in young infant with complex congenital heart disease

Wei Gao, Yu Zhong, Ai Min Sun et al. · International journal of cardiac imaging · 2016 · 30 citations

Medicine, Cardiology, Radiology +13

Discovery of GNE-149 as a Full Antagonist and Efficient Degrader of Estrogen Receptor alpha for ER+ Breast Cancer

Jun Liang, Robert A. Blake, Jae H. Chang et al. · ACS Medicinal Chemistry Letters · 2020 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

m6AmPred: Identifying RNA N6, 2′-O-dimethyladenosine (m6Am) sites based on sequence-derived information

Jie Jiang, Bowen Song, Kunqi Chen et al. · Methods · 2021 · 26 citations

Life Sciences, Bioinformatics, Molecular Biology +12